Uric acid and anti‐TNF antibody improve mitochondrial dysfunction in ob/ob mice
The mechanisms responsible for low mitochondrial respiratory chain (MRC) activity in the liver of patients with nonalcoholic steatohepatitis are unknown. In this study, we examined the cause of this dysfunction in ob/ob mice. Forty‐six mice were distributed in six groups: group I: C57BL/6J mice; gro...
Gespeichert in:
Veröffentlicht in: | Hepatology (Baltimore, Md.) Md.), 2006-09, Vol.44 (3), p.581-591 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 591 |
---|---|
container_issue | 3 |
container_start_page | 581 |
container_title | Hepatology (Baltimore, Md.) |
container_volume | 44 |
creator | García‐Ruiz, Inmaculada Rodríguez‐Juan, Cristina Díaz‐Sanjuan, Teresa del Hoyo, Pilar Colina, Francisco Muñoz‐Yagüe, Teresa Solís‐Herruzo, José A. |
description | The mechanisms responsible for low mitochondrial respiratory chain (MRC) activity in the liver of patients with nonalcoholic steatohepatitis are unknown. In this study, we examined the cause of this dysfunction in ob/ob mice. Forty‐six mice were distributed in six groups: group I: C57BL/6J mice; group II: C57BL/6J Lep(−/−) mice (ob/ob); group III, ob/ob mice treated with manganese [III] tetrakis (5,10,15,20 benzoic acid) porphyrin (MnTBAP); group IV, ob/ob mice treated with IgG1 immunoglobulin; group V, ob/ob mice treated with anti‐TNF antibody; group VI: ob/ob mice treated with uric acid. In liver tissue, we measured MRC activity, fatty acid β‐oxidation, tumor necrosis factor (TNF), inducible nitric oxide synthase (iNOS), 3‐tyrosine‐nitrated proteins, 3‐tyrosine‐nitrated mitochondrial proteins, including cytochrome c and ND4 subunit of complex I. MRC activity was decreased in ob/ob mice. TNF levels, iNOS protein expression, and tyrosine nitrated proteins were markedly increased in the liver of ob/ob mice. In these animals, mitochondrial proteins were markedly tyrosine nitrated, particularly the ND4 subunit of complex I and cytochrome c. Treatment of these animals with uric acid, a peroxynitrite scavenger, anti‐TNF antibody, or MnTBAP decreased tyrosine nitrated proteins, improved the activity of MRC complexes, and led to a marked regression of hepatic steatosis and inflammation. In conclusion, MRC dysfunction and liver lesions found in ob/ob mice are likely to reflect the tyrosine nitration of mitochondrial proteins by peroxynitrite or a peroxynitrite‐derivate radical. Increased hepatic TNF and iNOS expression might enhance peroxynitrite formation and inhibition of MRC complexes. (HEPATOLOGY 2006;44:581–591.) |
doi_str_mv | 10.1002/hep.21313 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68818947</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68818947</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4193-b8c2a1b7be3c84336cc59f3bbe8eed730334b95694afe6232d8f22b2a85699023</originalsourceid><addsrcrecordid>eNp10MtKAzEUBuAgiq3VhS8gs1FwMW0uc0mWUlorFC_QrkOSydDIzKROOsrsfASf0Scx7Qx05eKQQ_g45_ADcI3gGEGIJxu9HWNEEDkBQxTjNCQkhqdgCHEKQ4YIG4AL594hhCzC9BwMUMIilFA8BG_r2qhAKJMFotrXzvx-_6ye54dW2qwNTLmt7acOSrOzamOrrDaiCLLW5U2ldsZWgakCKydWeqL0JTjLReH0Vf-OwHo-W00X4fLl8Wn6sAxVhBgJJVVYIJlKTRSNCEmUillOpNRU6ywlkJBIstgfKnKdYIIzmmMssaD-j0FMRuCum-uv-2i02_HSOKWLQlTaNo4nlCLKotTD-w6q2jpX65xva1OKuuUI8n1-3OfHD_l5e9MPbWSps6PsA_PgtgfCKVHktaiUcUdHYeojRt5NOvdlCt3-v5EvZq_d6j8i8ocB</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68818947</pqid></control><display><type>article</type><title>Uric acid and anti‐TNF antibody improve mitochondrial dysfunction in ob/ob mice</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>García‐Ruiz, Inmaculada ; Rodríguez‐Juan, Cristina ; Díaz‐Sanjuan, Teresa ; del Hoyo, Pilar ; Colina, Francisco ; Muñoz‐Yagüe, Teresa ; Solís‐Herruzo, José A.</creator><creatorcontrib>García‐Ruiz, Inmaculada ; Rodríguez‐Juan, Cristina ; Díaz‐Sanjuan, Teresa ; del Hoyo, Pilar ; Colina, Francisco ; Muñoz‐Yagüe, Teresa ; Solís‐Herruzo, José A.</creatorcontrib><description>The mechanisms responsible for low mitochondrial respiratory chain (MRC) activity in the liver of patients with nonalcoholic steatohepatitis are unknown. In this study, we examined the cause of this dysfunction in ob/ob mice. Forty‐six mice were distributed in six groups: group I: C57BL/6J mice; group II: C57BL/6J Lep(−/−) mice (ob/ob); group III, ob/ob mice treated with manganese [III] tetrakis (5,10,15,20 benzoic acid) porphyrin (MnTBAP); group IV, ob/ob mice treated with IgG1 immunoglobulin; group V, ob/ob mice treated with anti‐TNF antibody; group VI: ob/ob mice treated with uric acid. In liver tissue, we measured MRC activity, fatty acid β‐oxidation, tumor necrosis factor (TNF), inducible nitric oxide synthase (iNOS), 3‐tyrosine‐nitrated proteins, 3‐tyrosine‐nitrated mitochondrial proteins, including cytochrome c and ND4 subunit of complex I. MRC activity was decreased in ob/ob mice. TNF levels, iNOS protein expression, and tyrosine nitrated proteins were markedly increased in the liver of ob/ob mice. In these animals, mitochondrial proteins were markedly tyrosine nitrated, particularly the ND4 subunit of complex I and cytochrome c. Treatment of these animals with uric acid, a peroxynitrite scavenger, anti‐TNF antibody, or MnTBAP decreased tyrosine nitrated proteins, improved the activity of MRC complexes, and led to a marked regression of hepatic steatosis and inflammation. In conclusion, MRC dysfunction and liver lesions found in ob/ob mice are likely to reflect the tyrosine nitration of mitochondrial proteins by peroxynitrite or a peroxynitrite‐derivate radical. Increased hepatic TNF and iNOS expression might enhance peroxynitrite formation and inhibition of MRC complexes. (HEPATOLOGY 2006;44:581–591.)</description><identifier>ISSN: 0270-9139</identifier><identifier>EISSN: 1527-3350</identifier><identifier>DOI: 10.1002/hep.21313</identifier><identifier>PMID: 16941682</identifier><identifier>CODEN: HPTLD9</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Animals ; Antibodies - therapeutic use ; Biological and medical sciences ; Blotting, Western ; Disease Models, Animal ; Enzyme-Linked Immunosorbent Assay ; Fatty Liver - drug therapy ; Fatty Liver - metabolism ; Fatty Liver - pathology ; Flow Cytometry ; Gastroenterology. Liver. Pancreas. Abdomen ; Hepatocytes - metabolism ; Hepatocytes - pathology ; Interferon-gamma - metabolism ; Interleukin-1 - metabolism ; Male ; Medical sciences ; Mice ; Mice, Inbred C57BL ; Mitochondria, Liver - drug effects ; Mitochondria, Liver - metabolism ; Mitochondrial Diseases - drug therapy ; Mitochondrial Diseases - metabolism ; Mitochondrial Diseases - pathology ; Nitric Oxide Synthase Type II - metabolism ; Treatment Outcome ; Tumor Necrosis Factor-alpha - immunology ; Uric Acid - therapeutic use</subject><ispartof>Hepatology (Baltimore, Md.), 2006-09, Vol.44 (3), p.581-591</ispartof><rights>Copyright © 2006 American Association for the Study of Liver Diseases</rights><rights>2006 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4193-b8c2a1b7be3c84336cc59f3bbe8eed730334b95694afe6232d8f22b2a85699023</citedby><cites>FETCH-LOGICAL-c4193-b8c2a1b7be3c84336cc59f3bbe8eed730334b95694afe6232d8f22b2a85699023</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fhep.21313$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fhep.21313$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18074281$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16941682$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>García‐Ruiz, Inmaculada</creatorcontrib><creatorcontrib>Rodríguez‐Juan, Cristina</creatorcontrib><creatorcontrib>Díaz‐Sanjuan, Teresa</creatorcontrib><creatorcontrib>del Hoyo, Pilar</creatorcontrib><creatorcontrib>Colina, Francisco</creatorcontrib><creatorcontrib>Muñoz‐Yagüe, Teresa</creatorcontrib><creatorcontrib>Solís‐Herruzo, José A.</creatorcontrib><title>Uric acid and anti‐TNF antibody improve mitochondrial dysfunction in ob/ob mice</title><title>Hepatology (Baltimore, Md.)</title><addtitle>Hepatology</addtitle><description>The mechanisms responsible for low mitochondrial respiratory chain (MRC) activity in the liver of patients with nonalcoholic steatohepatitis are unknown. In this study, we examined the cause of this dysfunction in ob/ob mice. Forty‐six mice were distributed in six groups: group I: C57BL/6J mice; group II: C57BL/6J Lep(−/−) mice (ob/ob); group III, ob/ob mice treated with manganese [III] tetrakis (5,10,15,20 benzoic acid) porphyrin (MnTBAP); group IV, ob/ob mice treated with IgG1 immunoglobulin; group V, ob/ob mice treated with anti‐TNF antibody; group VI: ob/ob mice treated with uric acid. In liver tissue, we measured MRC activity, fatty acid β‐oxidation, tumor necrosis factor (TNF), inducible nitric oxide synthase (iNOS), 3‐tyrosine‐nitrated proteins, 3‐tyrosine‐nitrated mitochondrial proteins, including cytochrome c and ND4 subunit of complex I. MRC activity was decreased in ob/ob mice. TNF levels, iNOS protein expression, and tyrosine nitrated proteins were markedly increased in the liver of ob/ob mice. In these animals, mitochondrial proteins were markedly tyrosine nitrated, particularly the ND4 subunit of complex I and cytochrome c. Treatment of these animals with uric acid, a peroxynitrite scavenger, anti‐TNF antibody, or MnTBAP decreased tyrosine nitrated proteins, improved the activity of MRC complexes, and led to a marked regression of hepatic steatosis and inflammation. In conclusion, MRC dysfunction and liver lesions found in ob/ob mice are likely to reflect the tyrosine nitration of mitochondrial proteins by peroxynitrite or a peroxynitrite‐derivate radical. Increased hepatic TNF and iNOS expression might enhance peroxynitrite formation and inhibition of MRC complexes. (HEPATOLOGY 2006;44:581–591.)</description><subject>Animals</subject><subject>Antibodies - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Blotting, Western</subject><subject>Disease Models, Animal</subject><subject>Enzyme-Linked Immunosorbent Assay</subject><subject>Fatty Liver - drug therapy</subject><subject>Fatty Liver - metabolism</subject><subject>Fatty Liver - pathology</subject><subject>Flow Cytometry</subject><subject>Gastroenterology. Liver. Pancreas. Abdomen</subject><subject>Hepatocytes - metabolism</subject><subject>Hepatocytes - pathology</subject><subject>Interferon-gamma - metabolism</subject><subject>Interleukin-1 - metabolism</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Mitochondria, Liver - drug effects</subject><subject>Mitochondria, Liver - metabolism</subject><subject>Mitochondrial Diseases - drug therapy</subject><subject>Mitochondrial Diseases - metabolism</subject><subject>Mitochondrial Diseases - pathology</subject><subject>Nitric Oxide Synthase Type II - metabolism</subject><subject>Treatment Outcome</subject><subject>Tumor Necrosis Factor-alpha - immunology</subject><subject>Uric Acid - therapeutic use</subject><issn>0270-9139</issn><issn>1527-3350</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp10MtKAzEUBuAgiq3VhS8gs1FwMW0uc0mWUlorFC_QrkOSydDIzKROOsrsfASf0Scx7Qx05eKQQ_g45_ADcI3gGEGIJxu9HWNEEDkBQxTjNCQkhqdgCHEKQ4YIG4AL594hhCzC9BwMUMIilFA8BG_r2qhAKJMFotrXzvx-_6ye54dW2qwNTLmt7acOSrOzamOrrDaiCLLW5U2ldsZWgakCKydWeqL0JTjLReH0Vf-OwHo-W00X4fLl8Wn6sAxVhBgJJVVYIJlKTRSNCEmUillOpNRU6ywlkJBIstgfKnKdYIIzmmMssaD-j0FMRuCum-uv-2i02_HSOKWLQlTaNo4nlCLKotTD-w6q2jpX65xva1OKuuUI8n1-3OfHD_l5e9MPbWSps6PsA_PgtgfCKVHktaiUcUdHYeojRt5NOvdlCt3-v5EvZq_d6j8i8ocB</recordid><startdate>200609</startdate><enddate>200609</enddate><creator>García‐Ruiz, Inmaculada</creator><creator>Rodríguez‐Juan, Cristina</creator><creator>Díaz‐Sanjuan, Teresa</creator><creator>del Hoyo, Pilar</creator><creator>Colina, Francisco</creator><creator>Muñoz‐Yagüe, Teresa</creator><creator>Solís‐Herruzo, José A.</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Wiley</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200609</creationdate><title>Uric acid and anti‐TNF antibody improve mitochondrial dysfunction in ob/ob mice</title><author>García‐Ruiz, Inmaculada ; Rodríguez‐Juan, Cristina ; Díaz‐Sanjuan, Teresa ; del Hoyo, Pilar ; Colina, Francisco ; Muñoz‐Yagüe, Teresa ; Solís‐Herruzo, José A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4193-b8c2a1b7be3c84336cc59f3bbe8eed730334b95694afe6232d8f22b2a85699023</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Animals</topic><topic>Antibodies - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Blotting, Western</topic><topic>Disease Models, Animal</topic><topic>Enzyme-Linked Immunosorbent Assay</topic><topic>Fatty Liver - drug therapy</topic><topic>Fatty Liver - metabolism</topic><topic>Fatty Liver - pathology</topic><topic>Flow Cytometry</topic><topic>Gastroenterology. Liver. Pancreas. Abdomen</topic><topic>Hepatocytes - metabolism</topic><topic>Hepatocytes - pathology</topic><topic>Interferon-gamma - metabolism</topic><topic>Interleukin-1 - metabolism</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Mitochondria, Liver - drug effects</topic><topic>Mitochondria, Liver - metabolism</topic><topic>Mitochondrial Diseases - drug therapy</topic><topic>Mitochondrial Diseases - metabolism</topic><topic>Mitochondrial Diseases - pathology</topic><topic>Nitric Oxide Synthase Type II - metabolism</topic><topic>Treatment Outcome</topic><topic>Tumor Necrosis Factor-alpha - immunology</topic><topic>Uric Acid - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>García‐Ruiz, Inmaculada</creatorcontrib><creatorcontrib>Rodríguez‐Juan, Cristina</creatorcontrib><creatorcontrib>Díaz‐Sanjuan, Teresa</creatorcontrib><creatorcontrib>del Hoyo, Pilar</creatorcontrib><creatorcontrib>Colina, Francisco</creatorcontrib><creatorcontrib>Muñoz‐Yagüe, Teresa</creatorcontrib><creatorcontrib>Solís‐Herruzo, José A.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Hepatology (Baltimore, Md.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>García‐Ruiz, Inmaculada</au><au>Rodríguez‐Juan, Cristina</au><au>Díaz‐Sanjuan, Teresa</au><au>del Hoyo, Pilar</au><au>Colina, Francisco</au><au>Muñoz‐Yagüe, Teresa</au><au>Solís‐Herruzo, José A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Uric acid and anti‐TNF antibody improve mitochondrial dysfunction in ob/ob mice</atitle><jtitle>Hepatology (Baltimore, Md.)</jtitle><addtitle>Hepatology</addtitle><date>2006-09</date><risdate>2006</risdate><volume>44</volume><issue>3</issue><spage>581</spage><epage>591</epage><pages>581-591</pages><issn>0270-9139</issn><eissn>1527-3350</eissn><coden>HPTLD9</coden><abstract>The mechanisms responsible for low mitochondrial respiratory chain (MRC) activity in the liver of patients with nonalcoholic steatohepatitis are unknown. In this study, we examined the cause of this dysfunction in ob/ob mice. Forty‐six mice were distributed in six groups: group I: C57BL/6J mice; group II: C57BL/6J Lep(−/−) mice (ob/ob); group III, ob/ob mice treated with manganese [III] tetrakis (5,10,15,20 benzoic acid) porphyrin (MnTBAP); group IV, ob/ob mice treated with IgG1 immunoglobulin; group V, ob/ob mice treated with anti‐TNF antibody; group VI: ob/ob mice treated with uric acid. In liver tissue, we measured MRC activity, fatty acid β‐oxidation, tumor necrosis factor (TNF), inducible nitric oxide synthase (iNOS), 3‐tyrosine‐nitrated proteins, 3‐tyrosine‐nitrated mitochondrial proteins, including cytochrome c and ND4 subunit of complex I. MRC activity was decreased in ob/ob mice. TNF levels, iNOS protein expression, and tyrosine nitrated proteins were markedly increased in the liver of ob/ob mice. In these animals, mitochondrial proteins were markedly tyrosine nitrated, particularly the ND4 subunit of complex I and cytochrome c. Treatment of these animals with uric acid, a peroxynitrite scavenger, anti‐TNF antibody, or MnTBAP decreased tyrosine nitrated proteins, improved the activity of MRC complexes, and led to a marked regression of hepatic steatosis and inflammation. In conclusion, MRC dysfunction and liver lesions found in ob/ob mice are likely to reflect the tyrosine nitration of mitochondrial proteins by peroxynitrite or a peroxynitrite‐derivate radical. Increased hepatic TNF and iNOS expression might enhance peroxynitrite formation and inhibition of MRC complexes. (HEPATOLOGY 2006;44:581–591.)</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>16941682</pmid><doi>10.1002/hep.21313</doi><tpages>11</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0270-9139 |
ispartof | Hepatology (Baltimore, Md.), 2006-09, Vol.44 (3), p.581-591 |
issn | 0270-9139 1527-3350 |
language | eng |
recordid | cdi_proquest_miscellaneous_68818947 |
source | MEDLINE; Access via Wiley Online Library; EZB-FREE-00999 freely available EZB journals |
subjects | Animals Antibodies - therapeutic use Biological and medical sciences Blotting, Western Disease Models, Animal Enzyme-Linked Immunosorbent Assay Fatty Liver - drug therapy Fatty Liver - metabolism Fatty Liver - pathology Flow Cytometry Gastroenterology. Liver. Pancreas. Abdomen Hepatocytes - metabolism Hepatocytes - pathology Interferon-gamma - metabolism Interleukin-1 - metabolism Male Medical sciences Mice Mice, Inbred C57BL Mitochondria, Liver - drug effects Mitochondria, Liver - metabolism Mitochondrial Diseases - drug therapy Mitochondrial Diseases - metabolism Mitochondrial Diseases - pathology Nitric Oxide Synthase Type II - metabolism Treatment Outcome Tumor Necrosis Factor-alpha - immunology Uric Acid - therapeutic use |
title | Uric acid and anti‐TNF antibody improve mitochondrial dysfunction in ob/ob mice |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T15%3A42%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Uric%20acid%20and%20anti%E2%80%90TNF%20antibody%20improve%20mitochondrial%20dysfunction%20in%20ob/ob%20mice&rft.jtitle=Hepatology%20(Baltimore,%20Md.)&rft.au=Garc%C3%ADa%E2%80%90Ruiz,%20Inmaculada&rft.date=2006-09&rft.volume=44&rft.issue=3&rft.spage=581&rft.epage=591&rft.pages=581-591&rft.issn=0270-9139&rft.eissn=1527-3350&rft.coden=HPTLD9&rft_id=info:doi/10.1002/hep.21313&rft_dat=%3Cproquest_cross%3E68818947%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=68818947&rft_id=info:pmid/16941682&rfr_iscdi=true |